These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 23219269
1. The immunoproteasome in antigen processing and other immunological functions. Basler M, Kirk CJ, Groettrup M. Curr Opin Immunol; 2013 Feb; 25(1):74-80. PubMed ID: 23219269 [Abstract] [Full Text] [Related]
2. Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentation. Basler M, Lauer C, Moebius J, Weber R, Przybylski M, Kisselev AF, Tsu C, Groettrup M. J Immunol; 2012 Aug 15; 189(4):1868-77. PubMed ID: 22772448 [Abstract] [Full Text] [Related]
3. The antiviral immune response in mice devoid of immunoproteasome activity. Basler M, Beck U, Kirk CJ, Groettrup M. J Immunol; 2011 Dec 01; 187(11):5548-57. PubMed ID: 22013127 [Abstract] [Full Text] [Related]
4. The 20S immunoproteasome and constitutive proteasome bind with the same affinity to PA28αβ and equally degrade FAT10. Schmidtke G, Schregle R, Alvarez G, Huber EM, Groettrup M. Mol Immunol; 2019 Sep 01; 113():22-30. PubMed ID: 29208314 [Abstract] [Full Text] [Related]
5. Immunoproteasome-specific inhibitors and their application. Basler M, Groettrup M. Methods Mol Biol; 2012 Sep 01; 832():391-401. PubMed ID: 22350900 [Abstract] [Full Text] [Related]
6. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i). Scheffler S, Kuckelkorn U, Egerer K, Dörner T, Reiter K, Soza A, Burmester GR, Feist E. Rheumatology (Oxford); 2008 May 01; 47(5):622-6. PubMed ID: 18375405 [Abstract] [Full Text] [Related]
7. Prevention of experimental colitis by a selective inhibitor of the immunoproteasome. Basler M, Dajee M, Moll C, Groettrup M, Kirk CJ. J Immunol; 2010 Jul 01; 185(1):634-41. PubMed ID: 20525886 [Abstract] [Full Text] [Related]
8. Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity. Basler M, Lindstrom MM, LaStant JJ, Bradshaw JM, Owens TD, Schmidt C, Maurits E, Tsu C, Overkleeft HS, Kirk CJ, Langrish CL, Groettrup M. EMBO Rep; 2018 Dec 01; 19(12):. PubMed ID: 30279279 [Abstract] [Full Text] [Related]
9. The immunoproteasome: a novel drug target for autoimmune diseases. Basler M, Mundt S, Bitzer A, Schmidt C, Groettrup M. Clin Exp Rheumatol; 2015 Dec 01; 33(4 Suppl 92):S74-9. PubMed ID: 26458097 [Abstract] [Full Text] [Related]
10. HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation. Yang Y, Liu W, Hu D, Su R, Ji M, Huang Y, Shereen MA, Xu X, Luo Z, Zhang Q, Liu F, Wu K, Liu Y, Wu J. mBio; 2020 Oct 27; 11(5):. PubMed ID: 33109760 [Abstract] [Full Text] [Related]
11. Immunoproteasomes are essential for survival and expansion of T cells in virus-infected mice. Moebius J, van den Broek M, Groettrup M, Basler M. Eur J Immunol; 2010 Dec 27; 40(12):3439-49. PubMed ID: 21108466 [Abstract] [Full Text] [Related]
12. Immunoproteasome subunit LMP2 expression is deregulated in Sjogren's syndrome but not in other autoimmune disorders. Krause S, Kuckelkorn U, Dörner T, Burmester GR, Feist E, Kloetzel PM. Ann Rheum Dis; 2006 Aug 27; 65(8):1021-7. PubMed ID: 16414974 [Abstract] [Full Text] [Related]
20. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies. Bhattarai S, Ghannam K, Krause S, Benveniste O, Marg A, de Bruin G, Xin BT, Overkleeft HS, Spuler S, Stenzel W, Feist E. J Autoimmun; 2016 Dec 27; 75():118-129. PubMed ID: 27522114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]